enen

News

CO2 Solutions Successfully Completes Second Oil Sands Project Milestones

News - CO2 Solutions, a leading innovator in the field of enzyme-enabled carbon capture technology, today announced that it has exceeded the second set of technical performance milestones for its oil sands project. CO2 Solutions patented process operated at the 0.5 ton/day scale and demonstrated that it can realistically lower the cost of CO2 capture to well below that associated with current carbon capture technology on the basis of cost per tonne captured.

Aeterna Zentaris: Poster Presentation at AACR Meeting Provides Rationale for New Therapeutic Opportunities in Oncology with Erk Inhibitors

News - Aeterna Zentaris announces that a poster on AEZS-134, a highly potent and selective ATP competitive Erk inhibitor, provides rationale for new therapeutic opportunities in oncology with this compound. The poster, titled, "Erk Inhibition as a Therapeutic Option for the Treatment of Raf- and Mek- Inhibitor Resistant Tumors", I. Seipelt, P. Schmidt, H. Märzhäuser, M. Gerlach, K. Jung, T. Schuster and M. Teifel, was presented yesterday by Irene Seipelt, Ph. D., Director, Preclinical Development at Aeterna Zentaris, during a poster session at the American Association for Cancer Research Annual Meeting in San Diego, California.

Offering "Express Entry" to Qualified Economic Immigrants - Actively Recruiting Talented Newcomers For the Benefit of Canada's Economy

News - Canada's Citizenship and Immigration Minister Chris Alexander today announced that Canada's active recruitment model for economic immigration will officially be called "Express Entry." Set to launch in January 2015, "Express Entry" is a major step forward in the transformation of Canada's immigration system into one that is fast, flexible and focused on meeting Canada's economic and labour needs.

Another year of growth for La Capitale

News - La Capitale was once again able to balance growth and profitability in 2013 and even surpass some of the ambitious goals set in its five-year strategic plan. "On the eve of its 75th anniversary, the company is stronger, more stable, and performing better than ever," declared René Rouleau, Chairman and Chief Executive Officer of La Capitale Civil Service Mutual during the Annual General Assembly held in Quebec City on April 7, 2014.

Atrium Innovations announces management transition

News - Atrium Innovations announces that Pierre Fitzgibbon, President and CEO of Atrium, will step down from the Company in 2014, by mutual agreement with the Board of Directors. Mr. Fitzgibbon will remain President and CEO while the Board conducts a search for his replacement and will continue to be one of Atrium's largest individual shareholders after his departure.

The Entrepreneurs: PetalMD prognosis good

News - Patrice Gilbert was convinced that the free network of online time management and communication services for physicians he launched four years ago would be a hit with Canadian doctors.

EXFO acquires ByteSphere's technologies to extend its service assurance offering in infrastructure performance visibility for mobile and fixed networks

News - EXFO announced today it has acquired the assets of ByteSphere LLC, a privately held software company in the Boston area that specializes in global IT management and network monitoring solutions.

Merck Canada announces $2-million grant to support personalized treatment in cancer

News - At the 6th Annual National Conference to Defeat Cancer, organized by Coalition Priorité Cancer, Merck Canada reinforced the company's continued commitment to the Quebec life sciences research innovation sector by announcing a $2-million grant to the Quebec - Consortium de recherche en oncologie clinique (Q-CROC).

Commendations: National Optics Institute (INO): The leader in generating technological innovation in Canada

News - Still buzzing from the festivities surrounding its 25th anniversary, National Optics Institute (INO) is proud to announce it has been recognized not once but twice in a study commissioned by the Saskatchewan Research Council (SRC).

An oral tritherapy that restores walking in paraplegics

News - Crowdfunding campaign for a Quebec-based company developing a tritherapy that can restore 'on-demand' walking for 45 min in experimental models of complete paralysis, wich is being tested in patients.

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page